Drug Type Antibody drug conjugate (ADC) |
Synonyms- |
Target |
Mechanism AMHR2 antagonists(Anti-Mullerian hormone receptor II antagonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC39H62N6O5S |
InChIKeyVNKVPXRCRUDPAH-JYZGKHMWSA-N |
CAS Registry- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Solid tumor | Preclinical | - | - |